Lincoln Alternative Strategies LLC's 7.54% Stake in BioCardia, Inc.

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing a 7.54% ownership stake in BioCardia, Inc. The filing indicates that Lincoln Alternative Strategies LLC beneficially owns 800,000 shares of BioCardia's common stock, with sole voting and dispositive power over these shares. The filing certifies that the shares were not acquired for the purpose of influencing the control of BioCardia. The filing was made under Rule 13d-1(c) and includes the signature of Stephen Temes, Managing Member of Lincoln Alternative Strategies LLC.